Navigation Links
Ranbaxy Receives Tentative Approval For Valsartan Tablets
Date:10/29/2007

To Benefit from 180 day exclusivity, at launch, due to its First To File

status

PRINCETON, N.J., Oct. 29 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Valsartan Tablets, 40 mg, 80 mg, 160 mg and 320 mg. Total annual market sales for Valsartan Tablets were $1.3 billion (IMS - MAT: June 2007).

Valsartan is indicated for the treatment of hypertension alone or in combination with other anti-hypertensive agents. Valsartan is also indicated for the treatment of heart failure (NYHA class II-IV).

"We are pleased to receive tentative approval for Valsartan Tablets. We believe, we are first to file a substantially complete ANDA and will stand to gain from the 180 day exclusivity available to the first filer. These product formulations have been developed organically within Ranbaxy and will further expand our product portfolio of affordable generic alternatives," said Jim Meehan, Vice President of Sales and Distribution for RPI.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical company. RPI is engaged in the sale and distribution of generic and branded prescription products in the U.S. healthcare system.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technol
'/>"/>

SOURCE Ranbaxy Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. RANBAXY - enters anti-AIDS segment
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Ranbaxy gets US FDA approval for Lisinopril
4. Ranbaxy Labs Entry Into Anti-Acne Market
5. Ranbaxy trying to make inroads in herbal drugs market
6. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
7. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
8. Ranbaxy opens Drug discovery centre in Gurgaon
9. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
10. SRL Ranbaxy offers quicker bird flu diagnostic test
11. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Steven Reinberg HealthDay Reporter , MONDAY, Jan. 3 ... have a greater risk of dying, especially from heart disease, ... conditions have a twofold increased risk of death, researchers say. ... of death," said lead researcher Dr. Frank B. Hu, a ...
... By Amanda Gardner HealthDay Reporter , MONDAY, Jan. 3 ... be offered free physicals, courtesy of the new Affordable Care Act. ... a person,s first year of enrollment in Part B, and the ... visit to be free. It,s part of an effort ...
... , MONDAY, Jan. 3 (HealthDay News) -- Treatment with ... energy and become less fatigued in just three weeks and ... just a placebo effect, a new study shows. People ... during the night when their airways become blocked. The condition ...
... role in controlling the populations of other insect species by laying ... hatched wasp gradually eats the host alive and takes over its ... however. In Drosophila (fruit flies), larvae activate humoral ... that encapsulates and chokes off the wasp egg. ...
... their mothers can play a key role in convincing them ... A study found that college-aged women were more likely ... had talked to their mother about it. "Mothers talking ... women were vaccinated," said Janice Krieger, lead author of the ...
... . . . They might get a pedestrian a ... in an electric wheelchair, they could mean terrain that,s ... address this problem, researchers at the Florida A&M University-Florida ... that will enable electric-powered wheelchairs to detect hazardous terrain ...
Cached Medicine News:Health News:In Women, Diabetes Plus Depression a Deadly Combo 2Health News:In Women, Diabetes Plus Depression a Deadly Combo 3Health News:First Physical With Medicare Now Free 2Health News:Common Sleep Apnea Therapy Relieves Fatigue: Study 2Health News:Parallels between cancers, infection suppression reported 2Health News:Mothers key to college-age women receiving HPV vaccine 2Health News:FSU researchers helping electric-wheelchair users move more easily 2Health News:FSU researchers helping electric-wheelchair users move more easily 3
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today announced completion of enrollment in its first ... the 3-month observations confirmed the 1-month findings that ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
(Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( http://bit.ly/1382OkS ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... , May 12 Carrot Medical, a ... MAVIG GmbH, the leading manufacturer of medical imaging monitor ... marketing and sales channel partnership agreement. This partnership provides ... through MAVIG,s global sales channel while offering MAVIG access ...
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Antifungal Drugs: Technologies and Global Markets , ... , , , ... , An examination of the major ...
Cached Medicine Technology:Carrot Medical Partners with MAVIG GmbH 2Carrot Medical Partners with MAVIG GmbH 3Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 2Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 3Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 4Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 5Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 6Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 7Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 8Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 9Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 10Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 11Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 12Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 13Reportlinker Adds Antifungal Drugs: Technologies and Global Markets 14
... Field (PEMF) bone growth stimulation delivered by ... long bone and small bone nonunions. Physio-Stim ... brace, or clothing without lessening its effectiveness. ... compact, lightweight unit including success rates as ...
Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer....
... Screws. Optimal screw design ... selection options. Robust threads ... and chamfered screw hub ... tissue fixation. Features a ...
Cannulated Interference Screws...
Medicine Products: